Kyto Technology and Life Science, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KBPH research report →
Price Chart
About the company
Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors.
- CEO
- Paul M. Russo
- IPO
- 2007
- Employees
- 1
- HQ
- Los Altos Hills, CA, US
Get TickerSpark's AI analysis on KBPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.29M
- P/E
- 16.67
- PEG
- 0.02
- P/S
- 0.00
- P/B
- 0.97
- EV/EBITDA
- 18.71
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 8.84%
- ROIC
- -21.25%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0+100.0%
- Op Income
- $-1,739,000
- Net Income
- $427.07K+155.2%
- EPS
- $0.06+146.2%
- OCF Growth
- -253.0%
- FCF Growth
- -253.0%
- 52W High
- $1.00
- 52W Low
- $1.00
- 50D MA
- $1.00
- 200D MA
- $1.00
- Beta
- 0.02
- RSI (14)
- 0
- Avg Volume
- 0
No earnings-call transcripts are available for KBPH yet.
- Free Float
- 73.2%
- Shares Outstanding
- 13.29M
- Float Shares
- 9.72M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 16, 21 | BENARROCH GEORGES | other | 181,250 |
| Mar 16, 21 | BENARROCH GEORGES | other | 181,250 |
| Jul 20, 20 | BENARROCH GEORGES | other | 50,000 |
| Oct 10, 19 | BENARROCH GEORGES | other | 150,000 |
| Dec 2, 20 | COMINDUS FINANCE CORP. | buy | 100,000 |
| Aug 29, 19 | COMINDUS FINANCE CORP. | buy | 12,500 |
| Apr 25, 18 | COMINDUS FINANCE CORP. | other | 400,000 |
| Apr 25, 18 | COMINDUS FINANCE CORP. | other | 400,000 |
| Feb 21, 18 | COMINDUS FINANCE CORP. | other | 958,752 |
| Feb 21, 18 | COMINDUS FINANCE CORP. | other | 958,752 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our KBPH coverage
Recent articles, reports, and earnings notes.
No research on KBPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KBPH report →